News release: Engineering innovation brings hope for a Parkinson’s cure (docx)
Global engineering company Renishaw has built a device that has been used in a ground-breaking clinical trial. Manufactured by Renishaw on behalf of the North Bristol NHS Trust, the device enabled the precise delivery of a new drug candidate, Glial Cell Line Derived Neurotrophic Factor (GDNF) with the hope of regenerating dying dopamine brain cells in people with Parkinson’s and thereby improve their symptoms.
This type of file requires a viewer, freely available from Microsoft
Latest videos - Neurological products and therapies
Latest items - Neurological products and therapies
Didn't find what you were looking for?
Tell us what you couldn’t find and we will do our best to help.